Drug Manufacturers - General (industry)

Compare top 5 →
OverviewAI BriefPerformanceCompositionScoresCompaniesNews
Q-Score62
Market Cap$4.5T
Aggregate P/E33.95
Dividend Yield1.92%
1Y Return+46.3%
Advancing (1M)71.43%
AI summary

Returns

+46.3%over the year
Cap-weightedMedianUp
1M+12.2%+5.3%71%
3M+14.1%+5.6%62%
YTD+26.9%+16.1%62%
1Y+46.3%+30.3%62%

Led by the largest companies: the median company returned +30.3%.

Returns by horizon and breadth

This month's movers

Leaders
  • LLYEli Lilly and Company+22.5%
  • GILDGilead Sciences, Inc.+17.7%
  • AZNAstraZeneca PLC+17.2%
  • GRFSGrifols, S.A.+17.1%
  • AMGNAmgen Inc.+14.2%
Laggards
  • JNJJohnson & Johnson-0.6%
  • OGNOrganon & Co.+0.7%
  • BMYBristol-Myers Squibb Company+1.2%
  • GSKGSK plc+3.6%
  • MRKMerck & Co., Inc.+5.3%
Every horizon's leaders and laggards

News sentiment

Open News

Largest companies

The map and every share

Size

Revenue$785.2B
Earnings$133.5B
Companies21
Concentration (HHI)0.15
Size and financials

Q-Score profile

62/ 100
Every score and metric

Valuation

Aggregate P/E33.95
Aggregate P/S5.77
Dividend yield1.92%
Earnings yield2.95%
Net margin17.00%
The valuation map

Revenue exposure

Outside the US38.71%
From Greater China—
Largest customer (avg.)—
Revenue covered78.50%
Size and financials